MLND · Categories · Form 3
MLND - SEC Form 3 initial insider statements
Millendo Therapeutics, Inc. (MLND) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for MLND
- SEC Form 3: Versant Venture Capital VI, L.P. claimed ownership of 2,176,411 units of Common Stock3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Pellizzari Christine A3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Whiting Samuel3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Xu Stella3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Brady Stephen R3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by RAAB MICHAEL3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Woiwode Thomas3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Lorenzo Pierre3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Dubensky Thomas W.3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SEC Form 3 filed by Lynn Jennifer Minai-Azary3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)